Cas:261710-79-6 5-Methylthiazole-4-carbaldehyde manufacturer & supplier

We serve Chemical Name:5-Methylthiazole-4-carbaldehyde CAS:261710-79-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

5-Methylthiazole-4-carbaldehyde

Chemical Name:5-Methylthiazole-4-carbaldehyde
CAS.NO:261710-79-6
Synonyms:5-methyl-4-Thiazolecarbaldehyde;5-methyl-thiazole-4-carbaldehyde;4-Thiazolecarboxaldehyde, 5-methyl-;5-Methyl-1,3-thiazole-4-carbaldehyde;5-methyl-4-thiazolecarboxaldehyde
Molecular Formula:C5H5NOS
Molecular Weight:127.164
HS Code:2934100090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:228.1±20.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.601
PSA:58.20000
Exact Mass:127.009186
LogP:1.26

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 5-methyl-4-Thiazolecarbaldehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-methyl-4-thiazolecarboxaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-methyl-thiazole-4-carbaldehyde Use and application,5-methyl-4-thiazolecarboxaldehyde technical grade,usp/ep/jp grade.


Related News: He pointed out that Taiwan had 10 confirmed cases, versus more than 14,000 in mainland China. 5-Methylthiazole-4-carbaldehyde manufacturer In a stringent xenograft model of disseminated lymphoblastic leukemia, FT819 demonstrated enhanced tumor clearance and control of leukemia as compared to primary CAR19 T cells. 5-Methylthiazole-4-carbaldehyde supplier He pointed out that Taiwan had 10 confirmed cases, versus more than 14,000 in mainland China. 5-Methylthiazole-4-carbaldehyde vendor The injection has previously proven to be as effective as standard daily pills with three active ingredients when administered monthly and also once every two months. 5-Methylthiazole-4-carbaldehyde factory ��Inceptua Medicines Access is delighted to be selected as Onconova��s partner for the Pre-approval Access Program for rigosertib.